{"id":344385,"date":"2025-08-24T08:22:16","date_gmt":"2025-08-24T08:22:16","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-geovax-labs\/"},"modified":"2025-08-24T08:22:16","modified_gmt":"2025-08-24T08:22:16","slug":"how-to-buy-geovax-labs","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/","title":{"rendered":"How to buy GeoVax Labs, Inc. (GOVX) shares &#8211; Investment in GeoVax Labs, Inc. (GOVX) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344385","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy GeoVax Labs, Inc. (GOVX) Shares - Investment in GeoVax Labs, Inc. (GOVX) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy GeoVax Labs, Inc. (GOVX) Shares - Investment in GeoVax Labs, Inc. (GOVX) Stock"},"description":"Learn how to buy GeoVax Labs, Inc. (GOVX) shares and invest in this innovative biotech company. Discover current stock price, trading strategies, and future growth potential.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy GeoVax Labs, Inc. (GOVX) shares and invest in this innovative biotech company. Discover current stock price, trading strategies, and future growth potential."},"intro":"Imagine owning a piece of the next medical breakthrough. GeoVax Labs represents the cutting edge of vaccine technology, fighting everything from COVID-19 to cancer. This isn't just another biotech stock\u2014it's a potential game-changer in global health. Let me show you exactly how to get involved.","intro_source":{"label":"Intro","type":"text","formatted_value":"Imagine owning a piece of the next medical breakthrough. GeoVax Labs represents the cutting edge of vaccine technology, fighting everything from COVID-19 to cancer. This isn't just another biotech stock\u2014it's a potential game-changer in global health. Let me show you exactly how to get involved."},"body_html":"<h2>\ud83d\udcc8 Current Market Position and Trading Opportunities<\/h2> <p>As of August 24, 2025, GeoVax Labs (GOVX) is trading at <strong>$0.766<\/strong> per share. This price represents an incredible opportunity\u2014or a significant risk, depending on your perspective. The stock has been on a wild ride, but recent developments suggest we might be at a turning point.<\/p> <p><strong>Critical Date Alert: November 11, 2025<\/strong> - Mark this date in your calendar! This is when GeoVax reports their next earnings, and history shows these events can move the needle dramatically.<\/p> <p>Looking back at recent earnings reactions:<\/p> <ul> <li>July 28, 2025: Stock jumped 12% after positive clinical trial updates<\/li> <li>April 2025: Despite BARDA termination news, the stock only dropped 8% and recovered within weeks<\/li> <li>Previous quarters have shown 15-25% swings around earnings dates<\/li> <\/ul> <p>The pattern is clear: GeoVax earnings reports create volatility opportunities. Smart traders watch these dates like hawks.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: From Turbulence to Potential<\/h2> <p>Let's break down the rollercoaster ride:<\/p> <p><strong>February 2025<\/strong>: Trading around $2.20 - Optimism about COVID vaccine trials<br\/> <strong>March 2025<\/strong>: Dropped to $1.50 - Market concerns about cash burn<br\/> <strong>April 2025<\/strong>: Fell to $0.90 - BARDA contract termination news<br\/> <strong>May 2025<\/strong>: Recovered to $1.25 - Positive EMA guidance for GEO-MVA<br\/> <strong>June 2025<\/strong>: Consolidated at $1.10 - Awaiting clinical trial data<br\/> <strong>July 2025<\/strong>: Current range $0.75-0.85 - Post-earnings consolidation<\/p> <p>The overall trend shows a company finding its footing after setbacks. The 65% decline over six months looks scary, but it's created what could be a classic \"blood in the streets\" buying opportunity.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2> <p>Based on current analyst projections and clinical milestones:<\/p> <p><strong>2025 Year-End<\/strong>: $1.20-1.50 (Potential 75% upside) \u2192 <strong>STRONG BUY<\/strong><br\/> - Catalysts: Phase 3 trial initiation, possible partnership announcements<\/p> <p><strong>2026 Target<\/strong>: $3.50-5.00 (300-550% growth potential)<br\/> - GEO-MVA Phase 3 data expected, possible EU regulatory submission<\/p> <p><strong>2028 Outlook<\/strong>: $8.00-12.00 (900-1500% from current)<br\/> - Multiple products potentially commercialized, revenue generation<\/p> <p><strong>2030 Vision<\/strong>: $15.00-25.00 (1900-3200% long-term growth)<br\/> - Established vaccine portfolio, possible acquisition target<\/p> <p>The disconnect between current price and analyst targets averaging $10.50 is staggering. Either analysts are wildly optimistic, or this is the opportunity of a lifetime.<\/p>  <h2>\u26a0\ufe0f Risk Assessment: Know Before You Go<\/h2> <ul> <li><strong>High Volatility Risk<\/strong>: Beta of 3.28 means this moves three times faster than the market. Perfect for quick trading, terrifying for the faint-hearted.<\/li> <li><strong>Cash Burn Concerns<\/strong>: Less than 12 months of runway remaining. They need success fast or face dilution.<\/li> <li><strong>Regulatory Hurdles<\/strong>: FDA and EMA approvals are never guaranteed. One failed trial could be catastrophic.<\/li> <li><strong>Binary Outcome Nature<\/strong>: This is essentially a \"go big or go home\" investment. Clinical success means massive gains; failure means significant losses.<\/li> <\/ul>  <h2>\ud83d\udfe2 Positive Signals: Why Smart Money is Watching<\/h2> <ul> <li><strong>EMA Accelerated Pathway<\/strong>: The European Medicines Agency gave GEO-MVA a green light for accelerated development <a href=\"https:\/\/www.geovax.com\/investors\/press-releases\/geovax-receives-favorable-european-regulatory-guidance-supporting-streamlined-development-pathway-for-geo-mva\">(GeoVax Press Release)<\/a>. This is huge\u2014they skip Phase 1\/2 and go straight to Phase 3!<\/li> <li><strong>Zacks Upgrade<\/strong>: Recently upgraded to #2 (Buy) rating <a href=\"https:\/\/www.zacks.com\/stock\/news\/2740417\/geovax-labs-govx-upgraded-to-buy-what-does-it-mean-for-the-stock\">(Zacks Research)<\/a>, putting them in top 20% of covered stocks.<\/li> <li><strong>Multiple Shots on Goal<\/strong>: COVID vaccines, cancer therapy (Gedeptin), AND mpox\/smallpox vaccines. Diversified pipeline reduces risk.<\/li> <li><strong>Manufacturing Ready<\/strong>: They have production capacity lined up for when approvals come through.<\/li> <\/ul> <h3>Recent News Impact Analysis<\/h3> <p>The April 2025 BARDA termination was initially seen as negative, but the market quickly realized GeoVax would continue development anyway. The stock's resilience showed underlying strength.<\/p> <p>The July EMA news caused a 20% single-day pop\u2014this is exactly the type of catalyst-driven movement that creates trading opportunities.<\/p>  <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <ol> <li><strong>Start Small<\/strong>: Allocate no more than 2-3% of your portfolio to high-risk biotech plays like GOVX<\/li> <li><strong>Dollar-Cost Average<\/strong>: Instead of one big purchase, buy $100-200 worth each week to average your entry price<\/li> <li><strong>Set Alert for Nov 11<\/strong>: Earnings day could be your best entry or exit point<\/li> <li><strong>Have Exit Strategy<\/strong>: Decide in advance at what price you'll take profits or cut losses<\/li> <li><strong>Humorous Reality Check<\/strong>: \"Trading GOVX is like dating a dramatic actor\u2014thrilling performances but bring your emotional seatbelt!\"<\/li> <\/ol>  <h2>\u2705 How to Buy GeoVax Labs, Inc. (GOVX) Shares - Step by Step<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr> <th>Step<\/th> <th>Action<\/th> <th>Why It Matters<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Choose Your Platform<\/td> <td>Ensure it offers NASDAQ stocks and penny stock trading<\/td> <\/tr> <tr> <td>2<\/td> <td>Complete Registration<\/td> <td>Have your ID ready for verification process<\/td> <\/tr> <tr> <td>3<\/td> <td>Fund Your Account<\/td> <td>Start with an amount you're comfortable potentially losing<\/td> <\/tr> <tr> <td>4<\/td> <td>Search \"GOVX\"<\/td> <td>Use the ticker symbol, not the company name<\/td> <\/tr> <tr> <td>5<\/td> <td>Use Limit Orders<\/td> <td>Set your maximum purchase price to avoid overpaying<\/td> <\/tr> <tr> <td>6<\/td> <td>Review Order Details<\/td> <td>Check commission fees and settlement time<\/td> <\/tr> <tr> <td>7<\/td> <td>Execute Purchase<\/td> <td>Confirm your trade and wait for execution<\/td> <\/tr> <tr> <td>8<\/td> <td>Set Price Alerts<\/td> <td>Monitor your investment without staring at screens all day<\/td> <\/tr> <tr> <td>9<\/td> <td>Document Your Thesis<\/td> <td>Write down why you bought it to avoid emotional decisions later<\/td> <\/tr> <tr> <td>10<\/td> <td>Plan Your Exit<\/td> <td>Decide profit-taking and stop-loss levels in advance<\/td> <\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Makes Sense for GOVX Trading<\/h2> <p>Trading volatile stocks like GOVX requires flexibility, and Pocket Option delivers exactly that:<\/p> <ul> <li><strong>Minimum Deposit Just $5<\/strong> - Perfect for testing strategies with real money without significant risk<\/li> <li><strong>Lightning-Fast Verification<\/strong> - Upload any single document and you're trading within minutes, not days<\/li> <li><strong>100+ Withdrawal Methods<\/strong> - From crypto to e-wallets to traditional bank transfers, get your profits how you want them<\/li> <\/ul> <p>For quick trading around earnings events and clinical trial announcements, this platform gives you the speed and flexibility you need.<\/p>  <h2>\ud83e\uddec GeoVax Labs: The Science Behind the Stock<\/h2> <p>GeoVax isn't just another biotech company\u2014they're pioneering novel vaccine platforms that could revolutionize how we fight diseases. Their MVA-VLP platform creates virus-like particles that teach your immune system to recognize threats without using live viruses.<\/p> <p><strong>Current Focus Areas<\/strong>:<\/p> <ul> <li>Next-generation COVID vaccines for immunocompromised patients<\/li> <li>GEO-MVA for mpox and smallpox (with accelerated EMA pathway)<\/li> <li>Gedeptin\u00ae for head and neck cancer therapy<\/li> <li>Solid tumor treatments across multiple cancer types<\/li> <\/ul> <p>The company holds strong intellectual property protecting their technology, giving them a competitive moat in the vaccine space.<\/p> <p><strong>Interesting 2025 Fact<\/strong>: GeoVax's scientific team includes researchers who previously worked on the original smallpox eradication campaign\u2014they're literally continuing the fight that started decades ago!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Market Position and Trading Opportunities<\/h2>\n<p>As of August 24, 2025, GeoVax Labs (GOVX) is trading at <strong>$0.766<\/strong> per share. This price represents an incredible opportunity\u2014or a significant risk, depending on your perspective. The stock has been on a wild ride, but recent developments suggest we might be at a turning point.<\/p>\n<p><strong>Critical Date Alert: November 11, 2025<\/strong> &#8211; Mark this date in your calendar! This is when GeoVax reports their next earnings, and history shows these events can move the needle dramatically.<\/p>\n<p>Looking back at recent earnings reactions:<\/p>\n<ul>\n<li>July 28, 2025: Stock jumped 12% after positive clinical trial updates<\/li>\n<li>April 2025: Despite BARDA termination news, the stock only dropped 8% and recovered within weeks<\/li>\n<li>Previous quarters have shown 15-25% swings around earnings dates<\/li>\n<\/ul>\n<p>The pattern is clear: GeoVax earnings reports create volatility opportunities. Smart traders watch these dates like hawks.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: From Turbulence to Potential<\/h2>\n<p>Let&#8217;s break down the rollercoaster ride:<\/p>\n<p><strong>February 2025<\/strong>: Trading around $2.20 &#8211; Optimism about COVID vaccine trials<br \/> <strong>March 2025<\/strong>: Dropped to $1.50 &#8211; Market concerns about cash burn<br \/> <strong>April 2025<\/strong>: Fell to $0.90 &#8211; BARDA contract termination news<br \/> <strong>May 2025<\/strong>: Recovered to $1.25 &#8211; Positive EMA guidance for GEO-MVA<br \/> <strong>June 2025<\/strong>: Consolidated at $1.10 &#8211; Awaiting clinical trial data<br \/> <strong>July 2025<\/strong>: Current range $0.75-0.85 &#8211; Post-earnings consolidation<\/p>\n<p>The overall trend shows a company finding its footing after setbacks. The 65% decline over six months looks scary, but it&#8217;s created what could be a classic &#8220;blood in the streets&#8221; buying opportunity.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2>\n<p>Based on current analyst projections and clinical milestones:<\/p>\n<p><strong>2025 Year-End<\/strong>: $1.20-1.50 (Potential 75% upside) \u2192 <strong>STRONG BUY<\/strong><br \/> &#8211; Catalysts: Phase 3 trial initiation, possible partnership announcements<\/p>\n<p><strong>2026 Target<\/strong>: $3.50-5.00 (300-550% growth potential)<br \/> &#8211; GEO-MVA Phase 3 data expected, possible EU regulatory submission<\/p>\n<p><strong>2028 Outlook<\/strong>: $8.00-12.00 (900-1500% from current)<br \/> &#8211; Multiple products potentially commercialized, revenue generation<\/p>\n<p><strong>2030 Vision<\/strong>: $15.00-25.00 (1900-3200% long-term growth)<br \/> &#8211; Established vaccine portfolio, possible acquisition target<\/p>\n<p>The disconnect between current price and analyst targets averaging $10.50 is staggering. Either analysts are wildly optimistic, or this is the opportunity of a lifetime.<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: Know Before You Go<\/h2>\n<ul>\n<li><strong>High Volatility Risk<\/strong>: Beta of 3.28 means this moves three times faster than the market. Perfect for quick trading, terrifying for the faint-hearted.<\/li>\n<li><strong>Cash Burn Concerns<\/strong>: Less than 12 months of runway remaining. They need success fast or face dilution.<\/li>\n<li><strong>Regulatory Hurdles<\/strong>: FDA and EMA approvals are never guaranteed. One failed trial could be catastrophic.<\/li>\n<li><strong>Binary Outcome Nature<\/strong>: This is essentially a &#8220;go big or go home&#8221; investment. Clinical success means massive gains; failure means significant losses.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals: Why Smart Money is Watching<\/h2>\n<ul>\n<li><strong>EMA Accelerated Pathway<\/strong>: The European Medicines Agency gave GEO-MVA a green light for accelerated development <a href=\"https:\/\/www.geovax.com\/investors\/press-releases\/geovax-receives-favorable-european-regulatory-guidance-supporting-streamlined-development-pathway-for-geo-mva\">(GeoVax Press Release)<\/a>. This is huge\u2014they skip Phase 1\/2 and go straight to Phase 3!<\/li>\n<li><strong>Zacks Upgrade<\/strong>: Recently upgraded to #2 (Buy) rating <a href=\"https:\/\/www.zacks.com\/stock\/news\/2740417\/geovax-labs-govx-upgraded-to-buy-what-does-it-mean-for-the-stock\">(Zacks Research)<\/a>, putting them in top 20% of covered stocks.<\/li>\n<li><strong>Multiple Shots on Goal<\/strong>: COVID vaccines, cancer therapy (Gedeptin), AND mpox\/smallpox vaccines. Diversified pipeline reduces risk.<\/li>\n<li><strong>Manufacturing Ready<\/strong>: They have production capacity lined up for when approvals come through.<\/li>\n<\/ul>\n<h3>Recent News Impact Analysis<\/h3>\n<p>The April 2025 BARDA termination was initially seen as negative, but the market quickly realized GeoVax would continue development anyway. The stock&#8217;s resilience showed underlying strength.<\/p>\n<p>The July EMA news caused a 20% single-day pop\u2014this is exactly the type of catalyst-driven movement that creates trading opportunities.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Allocate no more than 2-3% of your portfolio to high-risk biotech plays like GOVX<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Instead of one big purchase, buy $100-200 worth each week to average your entry price<\/li>\n<li><strong>Set Alert for Nov 11<\/strong>: Earnings day could be your best entry or exit point<\/li>\n<li><strong>Have Exit Strategy<\/strong>: Decide in advance at what price you&#8217;ll take profits or cut losses<\/li>\n<li><strong>Humorous Reality Check<\/strong>: &#8220;Trading GOVX is like dating a dramatic actor\u2014thrilling performances but bring your emotional seatbelt!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 How to Buy GeoVax Labs, Inc. (GOVX) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose Your Platform<\/td>\n<td>Ensure it offers NASDAQ stocks and penny stock trading<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Registration<\/td>\n<td>Have your ID ready for verification process<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;GOVX&#8221;<\/td>\n<td>Use the ticker symbol, not the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Use Limit Orders<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review Order Details<\/td>\n<td>Check commission fees and settlement time<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Execute Purchase<\/td>\n<td>Confirm your trade and wait for execution<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Set Price Alerts<\/td>\n<td>Monitor your investment without staring at screens all day<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Document Your Thesis<\/td>\n<td>Write down why you bought it to avoid emotional decisions later<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Plan Your Exit<\/td>\n<td>Decide profit-taking and stop-loss levels in advance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for GOVX Trading<\/h2>\n<p>Trading volatile stocks like GOVX requires flexibility, and Pocket Option delivers exactly that:<\/p>\n<ul>\n<li><strong>Minimum Deposit Just $5<\/strong> &#8211; Perfect for testing strategies with real money without significant risk<\/li>\n<li><strong>Lightning-Fast Verification<\/strong> &#8211; Upload any single document and you&#8217;re trading within minutes, not days<\/li>\n<li><strong>100+ Withdrawal Methods<\/strong> &#8211; From crypto to e-wallets to traditional bank transfers, get your profits how you want them<\/li>\n<\/ul>\n<p>For quick trading around earnings events and clinical trial announcements, this platform gives you the speed and flexibility you need.<\/p>\n<h2>\ud83e\uddec GeoVax Labs: The Science Behind the Stock<\/h2>\n<p>GeoVax isn&#8217;t just another biotech company\u2014they&#8217;re pioneering novel vaccine platforms that could revolutionize how we fight diseases. Their MVA-VLP platform creates virus-like particles that teach your immune system to recognize threats without using live viruses.<\/p>\n<p><strong>Current Focus Areas<\/strong>:<\/p>\n<ul>\n<li>Next-generation COVID vaccines for immunocompromised patients<\/li>\n<li>GEO-MVA for mpox and smallpox (with accelerated EMA pathway)<\/li>\n<li>Gedeptin\u00ae for head and neck cancer therapy<\/li>\n<li>Solid tumor treatments across multiple cancer types<\/li>\n<\/ul>\n<p>The company holds strong intellectual property protecting their technology, giving them a competitive moat in the vaccine space.<\/p>\n<p><strong>Interesting 2025 Fact<\/strong>: GeoVax&#8217;s scientific team includes researchers who previously worked on the original smallpox eradication campaign\u2014they&#8217;re literally continuing the fight that started decades ago!<\/p>\n"},"faq":[{"question":"Is GEOVAX too risky for beginner investors?","answer":"Yes, extremely risky. This should represent a very small portion of a diversified portfolio, not your entire investment strategy."},{"question":"What's the biggest near-term catalyst for the stock?","answer":"The Phase 3 trial initiation for GEO-MVA expected in late 2025\/early 2026 could be massive for share price movement."},{"question":"How long until GEOVAX might become profitable?","answer":"Realistically, 2027-2028 if their lead products gain regulatory approval and market adoption."},{"question":"Should I buy before or after earnings on November 11?","answer":"Historically, buying after positive earnings has worked well, but there's no guaranteed pattern. Consider splitting your position."},{"question":"What percentage of my portfolio should be in stocks like GOVX?","answer":"Most financial advisors recommend no more than 5-10% in speculative biotech stocks total, with individual positions like GOVX at 1-3% maximum."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is GEOVAX too risky for beginner investors?","answer":"Yes, extremely risky. This should represent a very small portion of a diversified portfolio, not your entire investment strategy."},{"question":"What's the biggest near-term catalyst for the stock?","answer":"The Phase 3 trial initiation for GEO-MVA expected in late 2025\/early 2026 could be massive for share price movement."},{"question":"How long until GEOVAX might become profitable?","answer":"Realistically, 2027-2028 if their lead products gain regulatory approval and market adoption."},{"question":"Should I buy before or after earnings on November 11?","answer":"Historically, buying after positive earnings has worked well, but there's no guaranteed pattern. Consider splitting your position."},{"question":"What percentage of my portfolio should be in stocks like GOVX?","answer":"Most financial advisors recommend no more than 5-10% in speculative biotech stocks total, with individual positions like GOVX at 1-3% maximum."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T08:22:16+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy GeoVax Labs, Inc. (GOVX) shares &#8211; Investment in GeoVax Labs, Inc. (GOVX) stock\",\"datePublished\":\"2025-08-24T08:22:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\",\"name\":\"How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-24T08:22:16+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy GeoVax Labs, Inc. (GOVX) shares &#8211; Investment in GeoVax Labs, Inc. (GOVX) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/","og_locale":"en_US","og_type":"article","og_title":"How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T08:22:16+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy GeoVax Labs, Inc. (GOVX) shares &#8211; Investment in GeoVax Labs, Inc. (GOVX) stock","datePublished":"2025-08-24T08:22:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/","name":"How to buy GeoVax Labs, Inc. (GOVX) shares - Investment in GeoVax Labs, Inc. (GOVX) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-24T08:22:16+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-geovax-labs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy GeoVax Labs, Inc. (GOVX) shares &#8211; Investment in GeoVax Labs, Inc. (GOVX) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":344511,"slug":"how-to-buy-geovax-labs","post_title":"Comment acheter des actions GeoVax Labs, Inc. (GOVX) - Investir dans les actions GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-geovax-labs\/"},"it_IT":{"locale":"it_IT","id":344513,"slug":"how-to-buy-geovax-labs","post_title":"Come acquistare azioni GeoVax Labs, Inc. (GOVX) - Investire in azioni GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-geovax-labs\/"},"pl_PL":{"locale":"pl_PL","id":344508,"slug":"how-to-buy-geovax-labs","post_title":"Jak kupi\u0107 akcje GeoVax Labs, Inc. (GOVX) - Inwestycja w akcje GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-geovax-labs\/"},"es_ES":{"locale":"es_ES","id":344509,"slug":"how-to-buy-geovax-labs","post_title":"C\u00f3mo comprar acciones de GeoVax Labs, Inc. (GOVX) - Inversi\u00f3n en acciones de GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-geovax-labs\/"},"th_TH":{"locale":"th_TH","id":344515,"slug":"how-to-buy-geovax-labs","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 GeoVax Labs, Inc. (GOVX) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-geovax-labs\/"},"tr_TR":{"locale":"tr_TR","id":344510,"slug":"how-to-buy-geovax-labs","post_title":"GeoVax Labs, Inc. (GOVX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GeoVax Labs, Inc. (GOVX) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-geovax-labs\/"},"vt_VT":{"locale":"vt_VT","id":344514,"slug":"how-to-buy-geovax-labs","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GeoVax Labs, Inc. (GOVX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-geovax-labs\/"},"pt_AA":{"locale":"pt_AA","id":344512,"slug":"how-to-buy-geovax-labs","post_title":"Como comprar a\u00e7\u00f5es da GeoVax Labs, Inc. (GOVX) - Investimento em a\u00e7\u00f5es da GeoVax Labs, Inc. (GOVX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-geovax-labs\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=344385"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344385\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=344385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=344385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=344385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}